Technical Analysis for BNGO - Bionano Genomics, Inc.

Grade Last Price % Change Price Change
F 0.97 -0.43% 0.00
BNGO closed down 0.43 percent on Friday, May 31, 2024, on 66 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
NR7 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Inside Day Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish -0.43%
Down 3 Days in a Row Weakness -0.43%
Fell Below 20 DMA Bearish -1.53%

   Recent Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bionano Genomics, Inc. Description

BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Its Saphyr system comprises an instrument, chip consumables, reagents, and a suite of data analysis tools. BioNano Genomics, Inc. also provides Bionano prep kits and labeling kits that provide the critical reagents and protocols needed to extract and label high molecular weight, or HMW, DNA for use with the Saphyr system; and data solutions that includes a suite of hardware and software for experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. The company was formerly known as BioNanomatrix, Inc. and changed its name to BioNano Genomics, Inc. in October 2011. The company was founded in 2003 and is headquartered in San Diego, California.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Genetics Genomics Algorithms Genome Informatics Bioinformatics Maps Cytogenetics Personal Genomics

Is BNGO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.2
52 Week Low 0.7143
Average Volume 1,342,895
200-Day Moving Average 1.65
50-Day Moving Average 0.98
20-Day Moving Average 1.03
10-Day Moving Average 1.04
Average True Range 0.08
RSI (14) 45.95
ADX 16.12
+DI 20.52
-DI 21.25
Chandelier Exit (Long, 3 ATRs) 0.96
Chandelier Exit (Short, 3 ATRs) 1.14
Upper Bollinger Bands 1.17
Lower Bollinger Band 0.89
Percent B (%b) 0.27
BandWidth 26.42
MACD Line 0.01
MACD Signal Line 0.02
MACD Histogram -0.0127
Fundamentals Value
Market Cap 37.6 Million
Num Shares 38.8 Million
EPS -7.17
Price-to-Earnings (P/E) Ratio -0.14
Price-to-Sales 1.42
Price-to-Book 0.40
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.04
Resistance 3 (R3) 1.05 1.03 1.03
Resistance 2 (R2) 1.03 1.01 1.03 1.03
Resistance 1 (R1) 1.00 1.00 0.99 0.99 1.02
Pivot Point 0.98 0.98 0.97 0.98 0.98
Support 1 (S1) 0.95 0.96 0.94 0.94 0.91
Support 2 (S2) 0.93 0.95 0.93 0.91
Support 3 (S3) 0.90 0.93 0.91
Support 4 (S4) 0.89